Mesoblast (MESO) Other Non-Current Liabilities (2015 - 2025)

Mesoblast (MESO) has reported Other Non-Current Liabilities for 11 consecutive years, with $14.2 million the latest figure, recorded in Q4 2025.

• Quarterly Other Non-Current Liabilities fell 48.59% year-over-year to $14.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.2 million (down 48.59% YoY) and the FY2025 annual result came in at $5.7 million, up 23.18% from the prior year.
• Other Non-Current Liabilities grew to $14.2 million in Q4 2025 per MESO's latest filing, from $5.7 million in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for MESO reached as high as $27.6 million in Q4 2024 and fell as low as $2.2 million in Q2 2022.
• A 5-year average of $15.2 million and a median of $17.7 million in 2022 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2023 — Other Non-Current Liabilities soared 148.33% — and 2025, when it slumped 48.59%.
• Year by year, Other Non-Current Liabilities stood at $22.3 million in 2021, then decreased by 19.9% to $17.9 million in 2022, then retreated by 4.37% to $17.1 million in 2023, then surged by 61.47% to $27.6 million in 2024, then sank by 48.59% to $14.2 million in 2025.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $14.2 million, $5.7 million, and $27.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.